Estimating antimicrobial resistance burden in Europe-what are the next steps?
Lancet Public Health
.
2022 Nov;7(11):e886-e887.
doi: 10.1016/S2468-2667(22)00250-X.
Epub 2022 Oct 14.
Authors
Nasreen Hassoun-Kheir
1
,
Stephan Harbarth
2
Affiliations
1
Infection Control Program, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva Switzerland.
2
Infection Control Program, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva Switzerland. Electronic address: stha@hcuge.ch.
PMID:
36244349
DOI:
10.1016/S2468-2667(22)00250-X
No abstract available
Publication types
Comment
MeSH terms
Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Europe / epidemiology
Humans
Substances
Anti-Bacterial Agents